Bioconversion of compactin into pravastatin by Streptomyces sp

Biotechnol Lett. 2003 Nov;25(21):1827-31. doi: 10.1023/a:1026281914301.

Abstract

Streptomyces sp. Y-110, isolated from soil, modified compactin to pravastatin, a therapeutic agent for hypercholesterolemia. In a batch culture, the highest production of pravastatin was 340 mg l(-1) from 750 mg compactin l(-1) in 24 h. By intermittent feeding of compactin into the culture medium, both the compactin concentration and its conversion increased to 2000 mg l(-1) and 1000 mg pravastatin l(-1), respectively, with the conversion rate of 10 mg l(-1) h(-1). Continuous feeding of compactin increased production of pravastatin to 15 mg l(-1) h(-1).

Publication types

  • Evaluation Study

MeSH terms

  • Bioreactors / microbiology*
  • Biotransformation
  • Cell Culture Techniques / methods*
  • Cell Division / physiology
  • Cytochrome P-450 Enzyme System / metabolism*
  • Lovastatin / analogs & derivatives*
  • Lovastatin / pharmacokinetics*
  • Pravastatin / biosynthesis*
  • Streptomyces / cytology
  • Streptomyces / growth & development*
  • Streptomyces / metabolism*

Substances

  • mevastatin
  • Cytochrome P-450 Enzyme System
  • Lovastatin
  • Pravastatin